SAN CARLOS, Calif., May 25, 2007 (BUSINESS WIRE) -- Nektar Therapeutics (NASDAQ:NKTR) announced that Howard W. Robin, president and chief executive officer of the company, will deliver the corporate presentation at the upcoming Bank of America 2007 Health Care Conference in Las Vegas on Thursday, May 31 at 4:40 p.m. PT.
The presentation and Q&A session will be accessible via a live audio-only Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until June 14, 2007.
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Tim Warner, 650-283-4915 twarner@nektar.com Stephan Herrera, 415-488-7699 sherrera@nektar.com
Copyright Business Wire 2007
News Provided by COMTEX